Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Damond

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Antimicrobial Chemotherapy|August 23, 2008
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitroB Roquebert, F Damond, G Collin, et al.
Journal of Clinical Microbiology|July 3, 1998
Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysisD Descamps, V Calvez, G Collin, et al.
Journal of Clinical Microbiology|November 29, 2001
Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCRF Damond, D Descamps, I Farfara, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2021
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infectionA Bachelard, V Isernia, D Vallois, et al.
AIDS Research and Human Retroviruses|December 2, 1999
An unusual HIV type 1 env sequence embedded in a mosaic virus from Cameroon: identification of a new env clade. European Network on the study of in utero transmission of HIV-1P Roques, E Menu, R Narwa, et al.
AIDS Research and Human Retroviruses|September 18, 2001
HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of MoldovaI Pandrea, D Descamps, G Collin, et al.
Medecine Et Maladies Infectieuses|July 22, 2010
[Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data]A Depatureaux, M Leoz, F De Oliveira, et al.
Journal of Clinical Microbiology|January 7, 2005
Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitorsF Damond, F Brun-Vezinet, S Matheron, et al.
Journal of Virological Methods|August 1, 1997
Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detectionJ Eberle, I Loussert-Ajaka, S Brust, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 4, 1999
V3 serotyping of HIV-1 infection: correlation with genotyping and limitationsJ C Plantier, F Damond, M Lasky, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|August 23, 2008
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitroB Roquebert, F Damond, G Collin, et al.
Journal of Clinical Microbiology|July 3, 1998
Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysisD Descamps, V Calvez, G Collin, et al.
Journal of Clinical Microbiology|November 29, 2001
Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCRF Damond, D Descamps, I Farfara, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2021
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infectionA Bachelard, V Isernia, D Vallois, et al.
AIDS Research and Human Retroviruses|December 2, 1999
An unusual HIV type 1 env sequence embedded in a mosaic virus from Cameroon: identification of a new env clade. European Network on the study of in utero transmission of HIV-1P Roques, E Menu, R Narwa, et al.
AIDS Research and Human Retroviruses|September 18, 2001
HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of MoldovaI Pandrea, D Descamps, G Collin, et al.
Medecine Et Maladies Infectieuses|July 22, 2010
[Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data]A Depatureaux, M Leoz, F De Oliveira, et al.
Journal of Clinical Microbiology|January 7, 2005
Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitorsF Damond, F Brun-Vezinet, S Matheron, et al.
Journal of Virological Methods|August 1, 1997
Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detectionJ Eberle, I Loussert-Ajaka, S Brust, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 4, 1999
V3 serotyping of HIV-1 infection: correlation with genotyping and limitationsJ C Plantier, F Damond, M Lasky, et al.
Pageof 4